Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedPage revision was updated from v3.6.4 to v3.6.5, signaling a software release or maintenance update to the ClinicalTrials.gov page. The update does not modify study details, eligibility criteria, or other content visible on the page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedResults have been submitted for this study record, replacing the previous 'No Results Posted' status. The page revision has been updated from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check42 days agoChange DetectedMilestone dates for the study were updated to reflect revised timelines, including the primary completion date and the estimated study completion. The date of the most recent update was added.SummaryDifference0.3%

- Check49 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3. This indicates a minor CMS update that does not modify study details or other substantive content on the page.SummaryDifference0.1%

- Check56 days agoChange DetectedFooter revision tag updated from v3.6.0 to v3.6.2, indicating a software version update for the page.SummaryDifference0.1%

- Check70 days agoChange DetectedNew page sections were added: No longer looking for participants, How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment header was added and the previous Intervention / Treatment header removed; the site revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.